abrdn Life Sciences Investors (HQL) To Go Ex-Dividend on August 24th

abrdn Life Sciences Investors (NYSE:HQL) announced a quarterly dividend on Tuesday, August 11th. Investors of record on Monday, August 24th will be given a dividend of 0.62 per share on Monday, August 31st. This represents a c) dividend on an annualized basis and a yield of 11.7%. The ex-dividend date of this dividend is Monday, August 24th. This is a 10.7% increase from abrdn Life Sciences Investors’s previous quarterly dividend of $0.56.

abrdn Life Sciences Investors Trading Up 0.6%

Shares of NYSE:HQL opened at $21.23 on Thursday. The firm’s 50 day moving average price is $19.19 and its 200-day moving average price is $17.84. abrdn Life Sciences Investors has a twelve month low of $13.44 and a twelve month high of $21.32.

About abrdn Life Sciences Investors

abrdn Life Sciences Investors (NYSE: HQL) is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.

The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.